Blog
RSS FeedPosted by Michael Wonder on 03 Jun 2021
The big pharma firm that saw the future
3 June 2021 - Long ago Roche bet on personalised health care. Now its time has come. ...
Posted by Michael Wonder on 11 Jan 2021
FDA takes steps to provide clarity on developing new drug products in the age of individualised medicine
4 January 2021 - Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug ...
Posted by Michael Wonder on 10 May 2020
COVID-19 raises questions about the value of personalised medicine
8 May 2020 - A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding ...
Posted by Michael Wonder on 09 Sep 2019
Inside drug makers' strategy to boost cancer medicines with 'Lazarus effect'
6 September 2019 - In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus ...
Posted by Michael Wonder on 28 Aug 2019
FDA warns testing companies: don’t tell patients how their DNA influences response to specific drugs
28 August 2019 - Amid a boom in genetic testing that aims to predict a person’s response to medication, the ...
Posted by Michael Wonder on 12 Sep 2018
Are we being misled about precision medicine?
12 September 2018 - Doctors and hospitals love to talk about the cancer patients they’ve saved, and reporters love to write ...
Posted by Michael Wonder on 28 Aug 2018
Comparison of two treatment models: precision medicine and preventive medicine
28 August 2018 - In an effort to improve the risk-benefit profile of therapies in clinical care, precision medicine seeks to ...
Posted by Michael Wonder on 23 Jul 2018
Precision medicine success hinges on diagnostics' clinical utility
23 July 2018 - The companion diagnostic plays a significant role in precision medicine. ...
Posted by Michael Wonder on 16 May 2018
Evolving landscape of US FDA drug approval in the era of precision oncology: finding the right balance between access and safety
15 May 2018 - Since 1992, the US FDA has implemented several programs for streamlined review and approval of agents that ...
Posted by Michael Wonder on 08 May 2018
Precision medicines have faster approvals based on fewer and smaller trials than other medicines
7 May 2018 - Precision medicines can benefit patients by increasing the probability of a successful treatment response in selected patient ...
Posted by Michael Wonder on 15 Dec 2017
Statement from FDA Commissioner on new FDA efforts to support more efficient development of targeted therapies
15 December 2017 - In recent years, the medical community has experienced a shift in the way health care is ...
Posted by Michael Wonder on 11 Jul 2017
Two recent scientific advances underscore an encouraging future for precision medicine at FDA
11 July 2017 - FDA helps bring precision medicine – in the form of targeted therapies — to people living ...
Posted by Michael Wonder on 22 Feb 2017
FDA’s Pazdur and Blumenthal: the march of checkpoint inhibitors will continue
21 February 2017 - More approvals of new immune-checkpoint inhibitors, targeted and personalised therapies, as well as the use of ...
Posted by Michael Wonder on 13 Feb 2017
The challenges of generating evidence to support precision medicine
13 February 2017 - Major recent advances in science and technology now enable new kinds of measurements that can characterise an ...
Posted by Michael Wonder on 13 Nov 2016
A precision medicine approach to clinical trials
14 November 2016 - Five or 6 years ago, only 5% to 10% of patients at David Hong's clinic arrived with ...